SANTA MONICA, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that a letter to shareholders from CEO Matthew Schissler has been posted on the Company's website. The letter explains some of the positive scientific and economic implications of the potential enhanced stem cell research initiatives proposed by the new Obama Administration.
On Sunday, November 9, 2008, John Podesta, who is leading President Elect Barack Obama's transition team, told Fox News (http://www.foxnews.com/story/0,2933,449164,00.html):
"We're looking at -- again, in virtually every agency to see where we can move forward, whether that's on energy transformation, on improving health care, on stem cell research.
There's a lot that the president can do using his executive authority without waiting for congressional action, and I think we'll see the president do that ..."
Mr. Schissler commented, "Because of this interview, there seems to be a rejuvenated and heightened awareness to stem cells and the philosophy change that is anticipated from our President Elect. It is my hope that, through a series of communicative letters to shareholders and families alike, that CBAI can provide valuable information from both a macroeconomic perspective, as well as a direct relation to the individual."
"I am often asked the question: 'What does this mean for Cord Blood
America?'" Mr. Schissler said. "Families ask us: 'What does this mean for
my family, should I store stem cells, what are the differences between
embryonic and adult stem cells, and what does the research mean to our
|SOURCE Cord Blood America, Inc.|
Copyright©2008 PR Newswire.
All rights reserved